5-Aminoimidazole-4-Carboxamide-1-β-4-Ribofuranoside (AICA-riboside) as a Targeting Agent for Therapy of Patients With Acute Lymphoblastic Leukemia: Are We There and Are There Pitfalls?
| Autor: | Bruce N. Cronstein, Barton A. Kamen |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
business.industry
medicine.drug_class Lymphoblastic Leukemia Antineoplastic Agents Carboxamide Hematology Precursor Cell Lymphoblastic Leukemia-Lymphoma Aminoimidazole Carboxamide Precursor Cell Lymphoblastic Leukemia Lymphoma 5-aminoimidazole Oncology Pediatrics Perinatology and Child Health Cancer research AICA riboside Humans Medicine Ribonucleosides Child business Beta (finance) |
| Zdroj: | Journal of Pediatric Hematology/Oncology. 29:805-807 |
| ISSN: | 1077-4114 |
| DOI: | 10.1097/mph.0b013e31815bbb83 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|